Prosecution Insights
Last updated: August 16, 2026
Application No. 18/271,386

METHOD FOR MASS SPECTROMETRY OF ORGANIC SYNTHETIC COMPOUND

Non-Final OA §102§112
Filed
Jul 07, 2023
Priority
Feb 10, 2021 — JP 2021-019934 +1 more
Examiner
JARRETT, LORE RAMILLANO
Art Unit
1797
Tech Center
1700 — Chemical & Materials Engineering
Assignee
SHIMADZU Corporation
OA Round
1 (Non-Final)
68%
Grant Probability
Favorable
1-2
OA Rounds
3m
Est. Remaining
94%
With Interview

Examiner Intelligence

Grants 68% — above average
68%
Career Allowance Rate
571 granted / 836 resolved
+3.3% vs TC avg
Strong +25% interview lift
Without
With
+25.2%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
21 currently pending
Career history
855
Total Applications
across all art units

Statute-Specific Performance

§101
3.0%
-37.0% vs TC avg
§103
33.4%
-6.6% vs TC avg
§102
23.0%
-17.0% vs TC avg
§112
31.1%
-8.9% vs TC avg
Black line = Tech Center average estimate • Based on career data from 836 resolved cases

Office Action

§102 §112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Applicant’s filing of claims 1-7 on 7/7/23 is acknowledged. Claims 1-7 are pending and are under examination. Information Disclosure Statement The information disclosure statement (IDS) submitted on 7/7/23 and 1/10/25 were acknowledged. Accordingly, the information disclosure statements are being considered by the examiner. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-7 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 1 is rejected because the scope of the preamble is unclear. The claim is missing a preamble, which includes the transitional term, e.g., “comprising”. Claim 1 is rejected for indefiniteness because the claim merely recites a use, e.g., “using,” without any active, positive steps delimiting how this use is actually practiced. See MPEP 2173.05(q). Claim 1 is rejected because it is unclear whether the negatively charged organic synthetic compound is being positively claimed. Claim 1 is rejected because the claim does not particularly point out and distinctly claim the relationship between the negatively charged organic synthetic compound, liquid matrix, ionic liquid, amine ion and acidic group-containing organic substance ion. The claim does not clearly claim what constitutes the liquid matrix and the ionic liquid. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-7 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Fukuyama et al. (“Fukuyama,” US Pub. No. 2015/0069226, cited in IDS). As to claims 1-4, Fukuyama teaches a method for mass spectrometry of a negatively charged organic synthetic compound (e.g., phosphorylated peptides), the method comprising using, as a liquid matrix, an ionic liquid comprising an amine ion (e.g., 3-aminoquinoline ion) and an acidic group-containing organic substance ion (e.g., p-coumaric acid). See abstract et seq. As to claim 5, see e.g., [0015] et seq. As to claims 6-7, see e.g., [0014] et seq. Any inquiry concerning this communication or earlier communications from the examiner should be directed to LORE RAMILLANO JARRETT whose telephone number is (571)272-7420. The examiner can normally be reached Monday to Friday. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Lyle Alexander can be reached at 571-272-1254. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /LORE R JARRETT/Primary Examiner, Art Unit 1797 1/10/2026
Read full office action

Prosecution Timeline

Jul 07, 2023
Application Filed
Jan 13, 2026
Non-Final Rejection mailed — §102, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12691445
IN-LINE TESTING DEVELOPMENT DIAGNOSTIC ANALYSIS
5y 11m to grant Granted Jul 28, 2026
Patent 12692848
MICROFLUIDIC VALVE, METHOD FOR ITS MANUFACTURE, AND USES THEREOF
3y 7m to grant Granted Jul 28, 2026
Patent 12678588
PACKAGED HYDROPHILIC MEDICAL PRODUCTS THAT ARE HYDRATED WITHIN THE PACKAGE AND METHODS OF MAKING THE SAME
4y 7m to grant Granted Jul 14, 2026
Patent 12661622
CONTINUOUS FLOW SYSTEMS WITH BIFURCATING MIXERS
5y 8m to grant Granted Jun 23, 2026
Patent 12661650
PBMC SEPARATION SYSTEMS AND METHODS OF USE
1y 3m to grant Granted Jun 23, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
68%
Grant Probability
94%
With Interview (+25.2%)
3y 4m (~3m remaining)
Median Time to Grant
Low
PTA Risk
Based on 836 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month